Stay updated with breaking news from Massimo Mineo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Microvillus inclusion disease (MVID) is a life-threatening and rare autosomal recessive disease that affects newborns and children and leads to significant morbidity and mortality from severe secretory
Napo Therapeutics is focused on expanding crofelemer access in Europe for treatment of patients suffering from rare diseases - beginning with short bowel syndrome For SBS, Napo... | January 24, 2022
2021 was a year of progress for Jaguar Health as the company advanced its key human pipeline initiatives focused on chemotherapy-related diarrhea (CTD) and short bowel syndrome with intestinal failure
SAN FRANCISCO, CA / ACCESSWIRE / December 20, 2021 /Jaguar Health, Inc. today announced that the name of its majority owned subsidiary changed from Napo EU S.p.A. to Napo Therapeutics S.p.A.... | December 20, 2021
The recognition of Orphan Drug Designation in Europe for crofelemer for this rare disease is the first key milestone of Napo EU under the company's exclusive license agreement with Jaguar HealthSAN FRANCISCO